Neogen Q1 FY2027 revenue $222.8M, up 6.5%; adjusted EPS $0.08; FY27 revenue and EBITDA guidance raised

NEOGEN CORP

2027-Q1 EPS reported -$0.05 revenue$222,800,000

Revenue of $222.8 million, up 6.5% YoY, with core growth of 8.1%; Food Safety revenue rose 7.4% (core growth 8.1%) and Animal Safety rose 4.2% (core growth 8.0%).
Net loss of $11.9 million, or $(0.05) per share; adjusted net income was $17.5 million and adjusted EPS was $0.08.
Adjusted EBITDA of $41.6 million at an 18.7% margin; cash flow from operations $12.9 million and free cash flow $4.7 million.
Neogen is on track to manufacture saleable Petrifilm product and begin its planned multi-quarter manufacturing transition in November 2026, with the first single kit unit (SKU) fully validated.
Company is raising fiscal year 2027 financial guidance for both revenue and Adjusted EBITDA.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.